Companies Related to "superinfection boosts immune response Findings provide insight into" [Most Relevant Company Matches] RSS

18:30 EDT 4th July 2015 | BioPortfolio

Here are the most relevant search results for "superinfection boosts immune response Findings provide insight into" found in our extensive corporate database of over 50,000 company records.

Showing "superinfection boosts immune response Findings provide insight into" Companies 1–25 of 4,600+

Relevant

The Immune Response Corporation

The Immune Response Corporation (OTCBB: IMNR.OB) is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimula...

Entelos Incorporated

Developing computer models of human physiology that simulate health, disease, and response to potential treatments, Entelos is bringing insight to the life sciences through technology.Currently focusing on metabolism and immune diseases, Entelos markets PhysioLabs for asthma and obesity. Models for HIV-AIDS, adipocyte, and diabetes are in development and will be released soon.

Immunitor Corporation Co., Ltd

Immunitor Corporation Co., Ltd., is the first private biotech company formed in Thailand Technology developed by Immunitor allows to formulate any desired immunogen or antigen as an oral tablet.Such antigens are formulated into an ordinary appearing pill in such a way that they can withstand the digestive degradation in the stomach but are capable to trigger immune response once pr...

Mucos Pharma GmbH & Co. KG

Millions of patients today trust Mucos Pharma’s innovative enzyme products. Thanks to its expertise in systemic enzyme therapy, Mucos Pharma has been a leader in the field for many years. Ever since Mucos Pharma started nearly 60 years ago, the enterprise continues to develop its international presence. Mucos Pharma is a future-oriented pharmaceutical initiative that possesses high sci...

Pharmexa A/S

Pharmexa is a leading company in the field of therapeutic vaccines (pharmaccines) for the treatment of serious chronic diseases. Pharmexa’s proprietary AutoVac™ pharmaccine technology platform is broadly applicable, but the company currently focuses its resources on a number of cancer forms and chronic inflammatory diseases. Pharmexa´s product pipeline targets breast cancer, rheumatoid arthri...

BIO-LOGIC SOLUTIONS

A start-up biomedical company with a novel approach to treating cancer. Our approach is logical. There are specific chemicals associated with tumors which block immune attack. By neutralizing these chemicals and stimulating immune response, we are able to initiate a spontaneous remission of the tumor.Our treatment concept has been accepted by the Patent Cooperation Treaty (PCT) as novel, inventi...

Orchestra Therapeutics

Orchestra Therapeutics’ unique approach to controlling autoimmune diseases uses small peptide vaccines that appear to stimulate FOXP3+ Regulatory T-cells; a component of the immune system that is now recognized as being key in autoimmune pathogenesis. Rather than disrupting the function of the entire immune system, these therapeutic vaccines are designed to elicit a very specific response – ak...

Insight Pharmaceuticals

Headquartered in Langhorne, PA, Insight Pharmaceuticals was founded in 1997 as a manufacturer and marketer of niche consumer over-the-counter medications that aid users in managing common ailments. The company's philosophy to provide effective medications that offer maximum relief for a variety of symptoms has led to the acquisition of such notable brands as Sucrets® Sore Throat and Cough Lozenge...

Immune Design Corp.

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches to enable the body’s immune system to fight disease. The company’s technologies are engineered to activate the immune system’s natural ability to create and/or expand antigen-specific cytotoxic T cells, while enhancing other immune effectors,...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Advaxis

Advaxis, Inc. is a biotechnology company that uses a modified infectious microorganism to activate the immune system to treat cancer, infectious disease or allergic syndromes. Based upon over a 10 years of innovative work done by Yvonne Paterson, Ph.D., Professor of Microbiology at the University of Pennsylvania, it has been found that the unique microbe Listeria monocytogenes is capable of stimul...

Church & Dwight, Co., Inc.

Church and Dwight, Co., Inc., headquartered in Princeton, NJ, distributes First Response Early Result Pregnancy Test and other First Response products, including First Response Gold Digital, First Response Rapid Result Pregnancy Test, First Response Easy Read Ovulation Test, First Response Daily Ovulation Test, First Response Fertility Test for Women, and Answer Pregnancy and Ovulation Tests.

Atox Bio

Established in 2003, Atox Bio is a clinical stage biotechnology company that develops therapeutics for diseases mediated by an excessive inflammatory response. Atox Bio focuses on novel modulators of the immune response that act broadly to attenuate excessive cytokine responses underlying disease, with therapeutic applications ranging from infectious to in...

Shared Health

With Clinical Insight, clinicians can access a practice management tool that presents a broad view of the care delivered across their patient population. Clinical Insight allows practices to generate reports that determine opportunities to provide care for specific groups of patients and ultimately improve outcomes for all patients.

FlowMetric Diagnostics Inc.

FlowMetric Diagnostics, an affiliate of FlowMetric Inc., based in Doylestown, PA and founded in December 2013, utilizes a flow cytometry-based platform to analyze cell-mediated immune responses. The company’s proprietary assays require only small volumes of capillary blood, eliminating the need for venous blood draw. The technology can be readily adap...

Activity Benchmarking Ltd

Activity Benchmarking Ltd is a UK-based company that has provided specialist benchmarking services to the pharmaceutical industry and its service sector since 1997. Main areas of focus are Marketing & Sales and Medical Departments in local affiliates in the UK and Spain and also HQ/regional functions in pharmaceutical companies. The comparative measurement of resource, activity and performance (on...

Medical Insight, Inc.

THE Aesthetic Show is a business unit of Medical Insight, Inc. and the largest medical education meeting focused completely on aesthetic medicine. To learn more, visit www.AestheticShow.com. Medical Insight, a progressive media company specializing in medical aesthetics, produces the leading trade publications and live events in this sector. THE Aesthetic Guide, published by Medical Insight, is w...

Vivaldi Biosciences Inc.

Vivaldi Biosciences is developing live attenuated influenza vaccines (LAIVs) with the potential for increased effectiveness in the prevention of emerging pandemic influenza and seasonal influenza. Vivaldi’s LAIVs are designed using proprietary reverse genetics and plasmid rescue technologies to truncate the influenza NS1 gene. The unique method of att...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Eye Clinic

We provide state of the art eye care guided by excellence and cutting edge knowledge. We discuss the findings of your eye exam with you and explain our recommendations, so you can obtain the best possible outcome.

Ultimovacs AS

Ultimovacs AS ('Ultimovacs') was established by Inven2 in 2011. The company's goal is to develop technology from the Norwegian Radium Hospital for use in cancer treatment and to make the treatment available to patients. The technology is based on the possibility of controlling the immune system to make it recognise and kill cancer cells. Ultimovacs is carr...

Center for Carpal Tunnel Studies

The Center for Carpal Tunnel Studies was established in1993 in Paradise Valley, Arizona by Dr. Benjamin M. Sucher. Since its inception, the Center has treated thousands of individuals and is continually engaged in documentation of clinical findings. The patient pool consists of individuals referred by outside medical providers as well as large numbers of individuals who have seen, read, or heard o...

Iomai

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, en...

Dimensional Insight

Dimensional Insight, www.dimins.com, solves business intelligence challenges for over 2600 clients globally. The Diver Solution, Dimensional Insight’s platform for aggregating data from multiple sources and distributing interactive reports, dashboards, and access for ad hoc analytics is named after the unique way users navigate complex data sets. Dime...

ImmunoBiology Limited (ImmBio)

Limited [ImmBio] is a biotechnology company specialising in the treatment of infectious diseases and cancer. ImmBio's approach is to apply advances in the emerging science of Immunobiology to the development of treatments for infections diseases and cancer. Immbio is developing a proprietary vaccine technology based on these advances. The platform technology is called HspC™ vaccination. HspC...


More From BioPortfolio on "superinfection boosts immune response Findings provide insight into"


Advertisement
 
Advertisement
 

Corporate Database Quicklinks